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Abstract
In mammals, parathyroid hormone (PTH) is a key regulator of extracellular calcium and inorganic phosphorus homeostasis.
Although the parathyroid glands were thought to be the only source of PTH, extra-parathyroid PTH production in the
thymus, which shares a common origin with parathyroids during organogenesis, has been proposed to provide an auxiliary
source of PTH, resulting in a higher than expected survival rate for aparathyroid Gcm22/2 mutants. However, the
developmental ontogeny and cellular identity of these ‘‘thymic’’ PTH–expressing cells is unknown. We found that the
lethality of aparathyroid Gcm22/2 mutants was affected by genetic background without relation to serum PTH levels,
suggesting a need to reconsider the physiological function of thymic PTH. We identified two sources of extra-parathyroid
PTH in wild-type mice. Incomplete separation of the parathyroid and thymus organs during organogenesis resulted in
misplaced, isolated parathyroid cells that were often attached to the thymus; this was the major source of thymic PTH in
normal mice. Analysis of thymus and parathyroid organogenesis in human embryos showed a broadly similar result,
indicating that these results may provide insight into human parathyroid development. In addition, medullary thymic
epithelial cells (mTECs) express PTH in a Gcm2-independent manner that requires TEC differentiation and is consistent with
expression as a self-antigen for negative selection. Genetic or surgical removal of the thymus indicated that thymus-derived
PTH in Gcm22/2mutants did not provide auxiliary endocrine function. Our data show conclusively that the thymus does not
serve as an auxiliary source of either serum PTH or parathyroid function. We further show that the normal process of
parathyroid organogenesis in both mice and humans leads to the generation of multiple small parathyroid clusters in
addition to the main parathyroid glands, that are the likely source of physiologically relevant ‘‘thymic PTH.’’
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Introduction
Mammals have evolved an integrated system consisting of the
parathyroid glands, bone, kidney and the intestine, to regulate
ionized calcium and inorganic phosphorus homeostasis in the
extracellular environment [1]. Circulating ionized Ca2+ and
inorganic phosphorus are required for a wide range of physiolog-
ical activities, including neuromuscular excitability, muscle
contraction, energy storage, bone mineralization, blood coagula-
tion and cardiovascular functions. Parathyroid hormone (PTH)
produced by the parathyroids acts as the key endocrine regulator
to modulate the physiological actions in the bone, kidney and the
intestine to maintain the homeostasis of ionized calcium and
inorganic phosphorus concentrations in the extracellular environ-
ment. Failure of calcium and phosphorus homeostasis, which can
result from PTH production disorders, causes serious physiological
consequences in human [2].
The parathyroid glands were long thought to be the sole source
of PTH production and secretion. However, analysis of the
aparathyroid Gcm2 null mouse mutant phenotype identified the
thymus, a primary lymphoid organ, as an auxiliary source of
circulating PTH in addition to the parathyroids in mice [3,4].
Thymic PTH was found to come from small clusters of
unidentified cells under the thymic capsule in wild-type mice,
although the ontogeny of these intrathymic PTH-expressing cells
and the regulation of PTH expression in these cells are not clear.
In humans, ectopic parathyroid cells have been found in a variety
of different locations, most commonly in the thymus [5], which
was thought to account for the origin of intrathymic parathyroid
adenomas in some patients [6]. However, the significance of
thymus-associated PTH for the survival of Gcm2 mouse mutants
was called into question by the phenotype of Pth null mutants,
which can survive in the complete absence of PTH [7,8].
Despite their distinct primary functions, the parathyroid and
thymus organs have a close relationship during organogenesis,
initially developing from two shared parathyroid/thymus primor-
dia originating from the bilateral 3rd pharyngeal pouches [9].
Analysis of mouse mutants has shown that initial formation and
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early patterning of the thymus and parathyroid domains are
controlled by a common regulatory pathway, including Hoxa3,
Pax1, Pax9 and Eya1 [10,11]. Once the organ domains are
specified, their differentiation is regulated by two different organ-
specific transcription factors, Gcm2 (for parathyroid) and Foxn1
(for thymus) [9]. In humans the bilateral 3rd and 4th pharyngeal
pouches are thought to give rise to four parathyroids [12–14]; the
pair of inferior parathyroid glands develop together with the
thymus from the 3rd pharyngeal pouches, while the pair of
superior parathyroid glands (not present in mice) develop with the
ultimobranchial bodies from the 4th pharyngeal pouches [5].
Accessory parathyroids have also been reported in animals and in
humans; although their origins were difficult to determine by
histology alone, these structures were proposed to originate either
during organogenesis, or to be induced postnatally in response to
experimentally or surgically induced hypoparathyroidism [12–15].
Furthermore, intrathymic parathyroid adenomas have been
hypothesized to originate from ‘‘ectopically migrating parathyroid
cells’’ [6].
The original analysis of the Gcm2 mutant mouse reported that
these mice were aparathyroid from embryonic stages [4]. Our
subsequent analysis of the role of Gcm2 in parathyroid
organogenesis showed that Gcm2 controls the differentiation
and survival of parathyroid precursor cells, but is not required to
specify the parathyroid domain within the pouch endoderm [3].
Without Gcm2 function, parathyroid precursor cells fail to
differentiate and then undergo apopotosis by embryonic day 12,
resulting in an aparathyroid phenotype [3,4]. Mutation of Gcm2
in humans has also been associated with hypoparathyroidism
[16,17]. However, the role of Gcm2 in the development of extra-
parathyroid PTH-expressing cells is as yet unknown.
To clarify the ontogenesis, regulation of PTH expression, and
physiological role of extra-parathyroid PTH-expressing cells, we
studied parathyroid and thymus organogenesis in the mouse. We
showed that clusters of ectopic parathyroid cells between the
parathyroid and thymus or attached to the thymus resulting from
incomplete separation of these two organs during normal
organogenesis. Analysis of parathyroid organogenesis in human
embryos showed a similar phenomenon. Absence of these
misplaced parathyroid cells in the thymus in Gcm22/2 mice
caused a significant decrease of thymic PTH expression but still
left a low level of thymic PTH expression, which we identified as
originating from mTECs expressing PTH in a Gcm2-independent
but Foxn1-dependent manner. Our results indicate that mTEC-
derived PTH is not secreted into the general circulation and does
not function as a backup mechanism of parathyroid glands, but
may function as a self-antigen for negative selection. We further
show that the lethality associated with Gcm2 mutation is not related
to the presence of thymic PTH or serum PTH levels. Our results
also have implications for the molecular mechanism of promiscu-
ous gene expression of tissue-restricted self-antigens in mTECs.
Our data also provide an explanation for the origin of ectopic
parathyroid adenomas that are often associated with human
hyperparathyroidism.
Results
Survival of Aparathyroid Gcm22/2 Mice Is Dependent on
Genetic Background without Rescue from
Hypoparathyroidism
We compared the phenotypes of Gcm22/2 mutants on the
C57BL/6J and 129/C57BL/6J F1genetic backgrounds for
survival and parathyroid function. We found that Gcm22/2
mutants on a C57BL/6J genetic background had a nearly 100%
lethality rate (Figure 1A), compared to 56% on the 129/C57BL/
6J F1genetic background (Figure 1B) and to about 30% with
additional backcross generations onto 129S6 (Table 1), confirming
the original report [4]. Analysis of fetal parathyroid organogenesis
in mutants from both genetic backgrounds confirmed our earlier
data showing a complete absence of Pth-positive parathyroid cells
[3] (Figure 2B, 2D and 2E). These data show that the reduced
lethality on the 129/C57BL/6J hybrid background is not due to
incomplete deletion of the parathyroids.
To test whether 129/C57BL/6J hybrid Gcm22/2 mutants had a
higher serum PTH concentration than the C57BL/6J Gcm22/2
mutants that failed to survive, we measured serum PTH levels in
E18.5 fetal Gcm22/2 mutants with different genetic backgrounds.
Most Gcm22/2 mutants on both genetic backgrounds had
undetectable serum PTH levels, with only a few individuals of
each genetic background showing variable levels above the
detection limit (3/23 for 129/C57BL/6J; 3/13 for C57BL/6J;
Figure 1C). This dramatic reduction of serum PTH levels in
Gcm22/2 mutants is consistent with other reports on a variety of
genetic backgrounds [18,19]. These results show that serum PTH
levels in the Gcm22/2 mutants are not affected by genetic
background, and that the lethality phenotype observed in
Gcm22/2 mutants is not related to serum PTH levels.
Heterozygotes on the 129/C57Bl6 hybrid genetic background
also had low or undetectable serum PTH levels. This difference in
steady-state PTH levels was not correlated with differences in
maternal ionized calcium levels, which were similar in heterozy-
gote and wild-type females from both strains, and parathyroid
glands in heterozygotes from the hybrid background were
histologically normal (data not shown). Variations in PTH levels
have been reported between C3H/HeJ and C57BL/6 mice,
including change in PTH levels in response to altering the calcium
content of the diet, as well as differences between strains in BMD,
calcium absorption, serum calcium, and calcitriol levels [20]. As
serum chemistry was normal, this result further supports our
observation that serum PTH levels do not correlate with lethality.
Author Summary
Due to the important role of PTH in the regulation of
physiological activities, disorders in PTH production can
cause many diseases in humans. Thus it is very important
to understand where PTH is produced and how it is
regulated. Many people have been found to have ectopic
and supernumerary parathyroid glands without clear
ontogenesis. In addition, the thymus, which develops
together with the parathyroid during embryogenesis, has
been proposed to be an auxiliary source of PTH with
endocrine function; however, PTH is also a tissue-restricted
self-antigen expressed by the thymus. In this paper, we
provide insights into the ontogeny and function of
thymus-associated PTH. We found that ectopic and
supernumerary parathyroid glands originate from the
normal developmental process underlying the separation
of parathyroid and thymus, resulting in misplaced
parathyroids close or attached to thymus. In the thymus,
thymic epithelial cells can produce a low level of PTH via a
different mechanism than the parathyroid and provide
functional data that TEC-derived PTH does not have
endocrine function. In summary, our data show that the
thymic source of PTH has no endocrine function and,
instead, has an expression pattern in the thymus
consistent with that of a self-antigen for negative
selection.
Two Cellular Origins for Thymic PTH
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Misplaced Parathyroid Cells Result from Incomplete
Parathyroid/Thymus Separation during Organogenesis
To investigate the possible role of thymic PTH in the lethality of
Gcm2 mutants, we designed experiments to determine the
ontogenesis of extra-parathyroid PTH-expressing cells. Since the
parathyroids and thymus arise from the same embryonic structure,
we tracked the process by which the parathyroid and thymus
domains resolve into separate primordia in mice using in situ
hybridization for Pth and Gcm2. At E12, Gcm2/Pth expression in
the parathyroid/thymus common primordia specifically marked
the anterior/dorsal Gcm2-positive parathyroid domain with a
clear interface at the posterior/ventral Foxn1-positive thymus
domain [3,21](Figure 2A-I). At E13, the Gcm2/Pth-positive
parathyroid domain had started to separate from the thymus
domain, and some parathyroid cells were located outside the
major parathyroid domain (Figure 2A-II). At E18.5, small clusters
of parathyroid cells were located between the parathyroids and
thymus or directly associated with the thymus, in some cases under
the developing thymic capsule (Figure 2A-III and 2C). This
phenotype was seen in all 11 E16.5-18.5 wild-type embryos on
multiple genetic backgrounds (C57BL/6J, 129/C57BL/6J F1
hybrid, or 129S6; Figure 2A–2D), which indicates that this
incomplete separation pattern is a common phenomenon in the
mouse.
RT-PCR using cDNA made from total thymus and other
organs from wild-type mice confirmed that co-expression of Gcm2
and Pth was detected only in the thymus (Figure 3A). Gcm2 and Pth
expression could be detected as early as E13.5 in dissected whole
thymus, when the thymus had just separated from the parathy-
roids, and at all later stages (Figure 3B).
If these misplaced Gcm2/Pth-positive cells are authentic
parathyroid cells, Gcm2 should regulate their differentiation and
survival [3]. As predicted, all misplaced parathyroid cells were
ablated in Gcm22/2 mutants (Figure 2B, 2D and 2E). The thymic
Pth expression level was also greatly reduced relative to wild-type,
while the expression of the TEC marker Foxn1 was not affected
(Figure 3C). These data suggest that misplaced parathyroid cells in
the thymus are the primary source of thymic PTH in wild-type
mice, and that these cells are absent in Gcm22/2 mutants.
Ectopic Parathyroid Tissue Is Observed in the Human
Embryo from Early Week 7
To test whether a similar phenomenon occurs in human
embryogenesis, we used whole-mount in situ hybridization for
Figure 1. Increased lethality of aparathyroid Gcm22/2 mutants on the C57BL/6J background is unrelated to serum PTH levels. (A)
The survival rate of mice born from Gcm2+/2 intercrosses on the C57BL/6J genetic background. Most Gcm22/2 mice died at the newborn stage. Mice
that survived more than 1 month were counted as survivors. (B) The survival rate of mice born from Gcm2+/2 intercrosses on the 129S6-C57BL/6J F1
hybrid background. In A and B, n = number of surviving adult mice. (C) PTH concentrations of wild-type, Gcm2+/2, and Gcm22/2 mice on the C57BL/
6J (B6) genetic background (from +/- intercrosses), and of Gcm2+/2and Gcm22/2mice from the hybrid genetic background (from +/2 x 2/2 crosses;
most females were +/2). .75% of mutants in both genetic backgrounds were below the level of detection of the assay (these values were reset at
the detection limit of 1.6).
doi:10.1371/journal.pgen.1001251.g001
Two Cellular Origins for Thymic PTH
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Gcm2 in early week 6 to mid week 8 human embryos or dissected
parathyroids and thymic lobes. At early week 6, Gcm2 was
expressed in the dorsal region of the 3rd and 4th pharyngeal
pouches (Figure 4A, 4B; 2/2 embryos). By early week 7 the
common parathyroid/thymic primordia (derived from the 3rd
pharyngeal pouch) have detached from the pharynx. Throughout
week 7, clusters of Gcm2 expressing cells were located in the
anterior portion of the common primordium (4/4 embryos) and at
the posterior tip (1/4 embryos) of the migrating elongated thymic
structure (Figure 4C–4H). Similar to the phenomenon we found in
mouse (Figure 2A-II), small clusters of ‘stray’ GCM2-positive cells
were often present (Figure 4E, *). By late week 7, although Gcm2
positive cells were still attached to the common primordia,
separate parathyroids were present, as well as small Gcm2
expressing clusters that may represent accessory parathyroids
(Figure 4F–4H; 1/1 embryo).
Dissected parathyroids and thymic lobes from one side of early
and mid week 8 embryos showed three major Gcm2 expressing
parathyroids (black arrowheads) and a smaller Gcm2 expressing
accessory parathyroid (red arrowhead) associated with a single
thymic lobe (Figure 4I–4K; 3/3 embryos). Of the major
parathyroid rudiments, one is clearly associated with the thymic
primordium at late week 7 and therefore appears to derive from
the 3rd pharyngeal pouch, while the other is clearly outside the
common thymus-parathyroid primordium and thus most likely
derives from the 4th pharyngeal pouch (note that GCM2 expression
is clearly evident in the 4th pouch at week 6) (Figure 4I–4K). In
addition, a smaller parathyroid rudiment was consistently
observed associated with the posterior tip of the thymus domain
of the common primordium at week 7 and week 8 (Figure 4D–4J),
although at least in late week 7 this appeared to be present only in
one of the two bilateral primordia (Figure 4H). Furthermore, as
the parathyroid separates, some Gcm2 expressing cells are left
attached to the upper cordlike thymic structure (Figure 4J, 4K,
white arrows). These data demonstrate that similar to our
observations in the mouse, ectopic parathyroids exist from week
7 in the human embryo, and that the presence of intrathymic
parathyroids in adulthood may be in part due to incomplete
separation from the thymus.
Thymic Epithelial Cells Express Thymic PTH Via a Gcm2-
Independent Pathway
RT-PCR using total thymus cDNA from Gcm22/2 mice could
still amplify Pth at high cycle numbers (Figure 3C), suggesting that
the misplaced parathyroid cells were not the only source of thymic
PTH. Quantitative RT-PCR using total thymus cDNA from
wild-type and Gcm22/2 mice on a C57BL/6 genetic background
showed that the second source of thymic PTH in the Gcm22/2
mice is about 1/350 of the level in the wild-type mice on the
C57Bl/6 background (Figure 3D). We therefore investigated this
Gcm2-independent source of thymic PTH expression.
The thymus is a complex immune organ composed of
hematopoietic cell-derived thymocytes and multiple types of
stromal cells [22]. TECs play a required role in the production
of a self-restricted and self-tolerant T-cell repertoire through
positive selection and negative selection [22]. Negative selection
occurs in the medullary region, where medullary TECs (mTECs)
promiscuously express many tissue-restricted self-antigens (TRAs)
that are required for negative selection to establish central
tolerance and prevent autoimmunity [23]. To test whether thymic
PTH expression was due to TRA expression in mTECs, we
performed RT-PCR on sorted TECs (Figure 5). TECs expressed
both Foxn1 and Pth, and expression levels were similar in TECs
sorted from wild-type controls and Gcm22/2 mutants (Figure 5B
and 5C). We did not detect Gcm1 or Gcm2 expression in the
purified TECs (Figure 5C), indicating that Pth expression in these
cells is not controlled by Gcm2, and arguing against a previously
proposed role for Gcm1 in regulating thymic PTH expression [4].
Pth expression was not found in other thymic cell types by RT-
PCR or microarray analyses, including T cells, macrophages, and
dendritic cells (Figure 5B) [24]. Microarray data from sorted
mTECs or cTECs also showed that Pth transcripts were present
only in mTECs [24]. We further confirmed the expression of Pth in
mTECs using Rag22/2 mutant mice, which have a normal
cortical structure but lack an organized medulla [25,26]. Thymic
Pth expression was greatly reduced in Gcm22/2;Rag22/2 double
mutants (Figure 5D), although not totally ablated, consistent with
the incomplete block in mTEC differentiation in Rag2 mutants.
Analysis of Gcm2;Foxn1 Double Mutants
As a genetic test of the TEC origin of thymic Pth expression, we
generated Gcm22/2;Foxn1nu/nu double mutant mice that have no
parathyroids and in which TEC differentiation is blocked [27]. We
failed to detect any thymic Pth expression in the thymic epithelial
rudiments of Gcm2;Foxn1 double mutants (Figure 5E). These results
further supported the conclusion that thymic Pth expression has
only two sources: misplaced authentic parathyroid cells that
express Pth in a Gcm2-dependent manner; and differentiated
mTECs that express Pth independent of Gcm2.
The initial report of the Gcm2 single mutant phenotype invoked
the 100% neonatal lethality of Hoxa3 mutants, which are
aparathyroid and athymic, in support of the proposal that
thymus-derived PTH ameliorated the lethality phenotype of
Gcm2 mutants [4]. As Hoxa3 mutants have a variety of other
defects that could contribute to lethality [28,29], we used the
Gcm22/2; Foxn1nu/nu double mutants as a more appropriate test of
Table 1. Survival rates of thymectomized Gcm22/2 mutants and Gcm2+/2 control littermates on the 129S6 background at
weaning.
Experimental Group Total at newborn Survival at weaning Survival rate
Gcm2+/2 (no Surgery) 19 19 100%
Gcm22/2 (no Surgery) 24 17 70.8%
Gcm2+/2 (mock) 16 15 93.8%
Gcm22/2 (mock) 19 14 73.7%
Gcm2+/2 (thymectomy) 19 15 78.9%
Gcm22/2 (thymectomy) 10 6 60%
doi:10.1371/journal.pgen.1001251.t001
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this possibility. These double mutants have a specific genetic
deletion of both parathyroids and thymus, without any known
potentially confounding phenotypes. In double heterozygote
intercrosses, all genotypes were present in the expected Mendelian
ratios at the newborn stage. Adult mice had reduced numbers of
genotypes homozygous for the Gcm2 mutation (Table 2), consistent
with the rate of lethality of Gcm22/2mutants on this mixed genetic
background. Surprisingly, compared with a survival rate of about
55% for Gcm22/2 mutants in these crosses, Gcm22/2;Foxn1nu/nu
double mutants had a lower survival rate of about 18% (Table 2).
However, the ionized calcium and inorganic phosphorus concen-
trations in both newborn and adult mice were not significantly
different between wild-type and Foxn1nu/nu mutant mice, or
between Gcm22/2 mutants and Gcm2;Foxn1 double mutants
(Figure 6C–6F). These results indicate that Foxn1-dependent Pth
Figure 2. Incomplete separation of parathyroid and thymus
organs results in extra-parathyroid PTH production. Paraffin
section in situ hybridization for Gcm2 (A) and Pth (A–E); sections were
cut in the sagittal plane. In all figures, anterior is up, and dorsal is to the
right. Ages of embryos are in the upper left corner of each panel.
Probes used for in situ hybridization are in the lower right. (A) Wild-type
embryos at E12 (I), E13 (II) and E18.5 (III) show the separation of
parathyroid and thymus organs from the common primordium. The
parathyroid/thymus common primordia in panels A–I are outlined. (B)
Loss of both parathyroid gland and misplaced parathyroid cells in
Gcm22/2 mutants. (C) Location of PTH-expressing cells that were close
to or attached to the wild-type thymus. In panels A–C, embryos used
were on C57BL/6J genetic background. (D–E) The aparathyroid
phenotype caused by Gcm2 null mutation also happens in the 129S6
genetic background. (D) Section in situ hybridization for Pth in wild-type
E18.5 129S6 embryos shows the primary parathyroid (arrow) and
several misplaced parathyroid cells (arrowheads). (E) Analysis of Gcm2
null mutants shows the loss of all parathyroid cells on the 129S6 genetic
background. In all panels, black arrows point to the parathyroid. White
arrows point to the thymus domain. Arrowheads point to misplaced
parathyroid cells. pt, parathyroid; th, thymus; tr, thyroid. Scale bars
= 0.1 mm.
doi:10.1371/journal.pgen.1001251.g002
Figure 3. Pth expression in misplaced parathyroid cells was co-
expressed with Gcm2 and down-regulated in Gcm2-null mutant
mice. (A) RT-PCR using cDNA made from different tissues to show the
co-expression of Gcm2 with Pth only in thymus, but not in other organs
tested. (B) RT-PCR using thymus cDNA from different stages. The
expression of Gcm2 and Pth was detected in all stages tested. (C) Semi-
quantitative RT-PCR on thymus cDNA from newborn wild-type and
Gcm22/2mutants. PCR amplification cycle numbers are indicated at the
top. b-actin was used as a loading control. Foxn1 was a positive control
for TECs. Gcm2 transcripts were absent and Pth transcription levels were
much lower in Gcm22/2 mutants. (D) Realtime PCR of Pth was
performed for total thymus cDNA samples from wild-type and Gcm22/2
mutants on the C57BL/6J or 129S6 (129) and C57BL/6J (B6) F1 hybrid
background. In panel D, n = 4. RQ is the relative quantitative expression
level of Pth.
doi:10.1371/journal.pgen.1001251.g003
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expression in mTECs does not contribute to serum calcium
physiology. While the reason for the increased lethality of double
mutants is as yet unclear, these data provide further evidence that
the lethality phenotype of Gcm22/2 and Gcm22/2Foxn12/2
mutants was not PTH-related.
mTEC-Derived PTH Does Not Have Endocrine Function in
Gcm2-Null Mutant Mice
The initial report of the Gcm2 null mutant phenotype showed
that surgical removal of both the thymus and parathyroids from
wild-type adults resulted in lethality [4]. As our data shows that
parathyroid cells are normally associated with the thymus due to
the incomplete organ separation during development, this result
could have been due to the removal of thymus-associated
parathyroids, rather than to the removal of thymus-produced
PTH. Although there was no detectable serum PTH in most Gcm2
mutants (Figure 1C), we tested whether thymic PTH participates
in endocrine function by determining whether the removal of the
thymus from Gcm22/2 mutants would increase lethality on the
129/C57BL/6J hybrid background. First, we performed thymec-
tomy surgery on newborn Gcm22/2 mutants on the 129S-C57Bl/
6 genetic background. Unmanipulated and mock surgery groups
from the same 129S6/C57BL/6J hybrid genetic background were
used as controls. Thymectomized Gcm22/2 mutants did not show
increased lethality (Table 1), and serum biochemistry did not show
any difference in ionized calcium or inorganic phosphorus levels
between surviving Gcm22/2 mutants with mock surgery and
Gcm22/2 mutants with thymectomy (Figure 6A, 6B). These data,
in combination with the analysis of Gcm2;Foxn1 double mutants,
therefore demonstrate that the thymus does not provide any PTH-
related endocrine function in mice.
Discussion
Our data reveal two cellular sources of extra-parathyroid PTH.
The first source is misplaced authentic parathyroid cells that arise
during normal organogenesis, which express PTH in the same way
as the parathyroid glands and are ablated in the Gcm2 null
mutants. The second source is mTECs, which express PTH
independently of Gcm2, but dependent on Foxn1-mediated TEC
differentiation. We also define two different physiological functions
for the PTH derived from these two different sources. We propose
that parathyroid cells, including those in the main parathyroid
glands and the misplaced parathyroid cells, are the only
physiologically relevant postnatal source of serum PTH, and that
the thymus has no contribution to serum PTH or calcium
physiology. mTECs also express PTH, probably as a self-antigen,
but this PTH does not contribute to serum PTH for endocrine
function. This result is consistent with the lack of secretory
machinery in these cells used in the parathyroid cells to secrete
PTH into the circulation [30–32], and the likelihood that the PTH
translated in the mTECs is degraded into short peptides to be used
for negative selection.
Based on our observations in both mouse and human, the
separation process of the parathyroids from the thymus results in
multiple ‘‘micro-parathyroids’’ in addition to the main parathyroid
glands. Parathyroid adenomas have been found in the human
thymus, and have been shown to express Gcm2, indicating that
intrathymic adenomas could be the result of uncontrolled growth
of the misplaced parathyroid cells [5,6,33]. These misplaced
Figure 4. Ectopic parathyroids are present from week 7 in the
human embryo. Whole-mount in situ hybridization for GCM2 (A–D, F,
H–K) and whole-mounts embedded in paraffin and sectioned after in
situ hybridization (E, G). Ages of embryos or dissected parathyroid/
thymus primordia in the lower right corner of A, C, and F apply to the
entire row; age in J also applies to K. The entire thymus/parathyroid
common primoridum is outlined in D, F, G, and H. In panels D–K, black
arrows show presumptive primary parathyroids, small arrowheads
indicate GCM2-positive clusters at the posterior end of the thymus, and
red arrows show probable accessory parathyroids. White arrows in J
and K show trailing GCM2-positive cells. (A, B) Side (A) and frontal (B)
views show GCM2 expression in the 3rd and 4th pharyngeal pouches in
an early week 6 embryo (2/2 embryos). (C–E) Images of whole-mount
(C, D) and paraffin sectioned (E, section from D) early to mid week 7
dissected parathyroid/thymus common primordia showing GCM2
expressing cells present in the anterior (4/4 embryos) and posterior
tip (1/4 embryos) of the common primordia. Small ectopic clusters away
from the main cluster (*) are also often present by this stage. (F) Image
shows separation of parathyroids from the common primordia is
occurring by late week 7 (right arrow; 1/1 embryo; the posterior
parathyroid was present in only one of the two common primordia in
this embryo). (G) Paraffin section of whole mount shown in F. (H) Whole
mount showing bilateral primordia (outlined) and carotid artery
complex (red dashed line), with four main parathyroids and one small
parathyroid cluster on the posterior tip of one thymic lobe. (I, J) Thymic
lobes and surrounding parathyroids from one side each of two separate
early week 8 embryos show Gcm2 expression by three apparent
primary parathyroids and a smaller accessory parathyroid (red arrow; 3/
3 embryos; in each case the thymus/parathyroid primordium was
examined from only one side of the embryo). The white arrow points to
Gcm2 expressing cells that are still attached to the thymic domain. (K)
higher magnification of the region boxed in J. pt, parathyroid; th,
thymus; p3, 3rd pharyngeal pouch; p4, 4th pharyngeal pouch.
doi:10.1371/journal.pgen.1001251.g004
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parathyroid cells could receive signals from the inappropriate
microenviroment, causing them to secrete high PTH or over-
proliferate; alternatively, these small groups of parathyroid cells
may respond inappropriately to homeostatic mechanisms.
Our analysis presents the first genetic marker study of human
parathyroid development, and reveals new information about
parathyroid development that differs from the original descriptions
of human parathyroid organogenesis based on histological studies.
Our results on the ontogeny of these extra-parathyroid PTH-
expressing cells provides insight into understanding the etiology of
some hyperparathyroid disorders caused by ectopic parathyroid
glands and intrathymic parathyroid adenomas [5,6]. It is widely
accepted that in humans four parathyroids develop during
embryogenesis, giving rise to the superior and inferior parathy-
roids, and that ectopic and supernumerary parathyroids, often
associated with the thymus, can cause primary hyperparathyroid-
ism due to hyperplasia, adenomas, and carcinomas [5,34]. Our
data indicate that more than four major parathyroid rudiments are
present by week 7 in the human fetus and that accessory
parathyroids are present in the majority of fetuses at week 7 to
week 8, and are therefore more frequent than previously
documented [12,35]. Our ability to identify these additional
parathyroid structures is due to the increased resolution of analysis
provided by in situ hybridization. Morphological studies would not
identify all of the smaller accessory parathyroids, and may have
annotated some parathyroid primordia as other structures.
Figure 5. mTEC-derived PTH expression is Gcm2-independent but requires Foxn1-mediated TEC differentiation. (A) TEC sorting from
control or Gcm22/2 adult thymi. TEC were labeled by activating expression from the R26YFP indicator using Foxn1Cre; cells were stained with anti
CD45-PE to gate out CD45+ thymocytes. FACS analysis was used to check the purity after cell sorting. (B) Real-time PCR for Pth was performed on
cDNA synthesized from sorted TECs from wild-type and Gcm22/2 adult thymi. Sorted CD45+ thymocytes were negative for Pth. (C) RT-PCR using
cDNA synthesized from sorted TECs from wild-type (WT) or Gcm22/2 adult thymi. (D) Real-time PCR for Pth from total thymus cDNA samples from
newborn wild-types (WT), Rag22/2, Gcm22/2, and Gcm22/2;Rag22/2 mutants. (E) Real-time PCR for Pth from total thymus from newborn wild-types,
Foxn1nu/nu, Gcm22/2, and Gcm22/2;Foxn1nu/nu mutants. RQ is the relative quantitative expression level of Pth. In panels B,D and E, n =number of
thymi analyzed.
doi:10.1371/journal.pgen.1001251.g005
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In our view, it is not yet possible to definitively determine the
relationship of the four GCM2-positive structures at week 8 to
those present at late week 7, since the thymus and parathyroid
primordia are actively migrating at this stage in development
and lineage tracing studies are not possible in human embryos.
The two GCM2-positive structures associated with the anterior
end of the thymus primordium at week 8 may correspond to the
major parathyroid foci present at late week 7 (i.e. to the
structures we assign as arising from the 3rd and 4th pharyngeal
pouches), while those at the posterior tip of the thymus
primordium correspond to the Gcm2-positive clusters at the
posterior in week 7. However, it is also possible that these both
anterior parathyroids arise from the 3rd pharyngeal pouch and
that the 4th pouch-derived parathyroid is no longer associated
with the thymus primordium and therefore is not dissected out
along with the thymus. In our view, the question of which of the
parathyroid rudiments present in human fetal development give
rise to the inferior and superior parathyroids in the adult also
remains open, and will require further detailed study for its
resolution.
Our original interest in this project was piqued by the
differences in lethality between the Gcm2 null mutants on different
genetic backgrounds, from ,30–60% on 129/C57BL/6J hybrid
background (this report; [4]), to nearly 100% on the C57BL/6J
background (this report). The original report of the Gcm2 null
mutants proposed that that thymic PTH could in part rescue an
aparathyroid lethality phenotype; the lethality of thyroid-parathy-
roid-thymectomy in adult wild-type mice, and of athymic and
aparathyroid Hoxa3 null mutants were listed in support of this
model [4]. It was later shown that Pth2/2 mice can survive [7,8],
calling into question the assumption that aparathyroidism in mice
would necessarily be lethal. Our data indicate that the lethality
phenotype in Gcm22/2 mutants is not related to serum PTH
levels; however, the question of why these mutants die is still not
resolved. There are also unexplained differences in survival of
different parathyroid-related mutants on the same background. A
recent study from the Kovacs lab suggests that the measurable
levels of PTH in some Gcm22/2 mutants at fetal stages may reflect
Gcm2-independent PTH originating from the placenta. However,
other than increased placental calcium transport, the Gcm2 and Pth
null mutants have very similar phenotypes, both of which are
milder than the Hoxa3 null when all are on the Black Swiss genetic
background [19]. Hoxa3 null mutants have phenotypes similar to
the PTH/PTHrP null, which also die at birth, suggesting that
Hoxa3 may play some role in calcium physiology outside the
parathyroid. In part, the answer may lie outside of calcium
physiology. Hoxa3 mutants have other defects that could
contribute to lethality [28,29]. The increased postnatal lethality
of the Gcm2;Foxn1 double mutants may also be due to as yet
unidentified functions for both of these transcription factors in
other tissues; expression of both Foxn1 and Gcm2 has been
identified in the postnatal central nervous system (http://mouse.
brain-map.org/brain/Foxn1.html; http://www.ncbi.nlm.nih.gov/
projects/gensat/).
Two models have been proposed for the mechanism that
regulates the promiscuous expression of TRAs in mTECs. The
progressive restriction model proposes a mosaic of TRA
expression in immature mTECs characteristic of multi-lineage
differentiated cells of endoderm-derived organs, and expressed by
the same tissue-specific regulators as in their ‘normal’ tissues [36].
In contrast, the terminal differentiation model proposes that some
mTECs have an autonomous property to express TRAs by a
different mechanism compared to their tissue-specific regulation,
characterized by lower transcriptional levels and independence
from tissue-specific transcriptional regulators [24]. This latter
model is supported by single-cell PCR of individual mTECs, and
by the analysis of casein beta gene expression in mTECs
compared to mammary gland cells [37]. Given the pharyngeal
endodermal origin of parathyroid cells, PTH should be a good
candidate for the progressive restriction model, as discussed
above. However, our data showed a much lower Pth expression
level in mTECs and a Foxn1-dependent and Gcm2-independent
pathway for PTH expression in mTECs, more consistent with the
terminal differentiation model; Gcm2-dependent PTH in the
thymus came exclusively from misplaced parathyroid cells.
Microarray analysis indicates that PTH expression in mTECs is
Aire-independent [38], consistent with immunolocalization
studies [39]. It is still an open question whether the regulation
mechanism for thymic PTH in mTECs is common to other Aire-
independent TRAs.
Table 2. Survival rates of Gcm22/2 single and Gcm22/2; Foxn1nu/nu double mutants on the 129S6/C57Bl6 hybrid background at
weaning.
Genotype Mendel Ratio Observed number Expected number Survival rate d2 d2/e
Gcm2+/+; Foxn1+/+ 9/16 116 102.375 185.6 1.81
Gcm2+/+; Foxn1nu/+
Gcm2+/2; Foxn1+/+
Gcm2+/2; Foxn1nu/+
Gcm2+/+; Foxn1nu/nu 3/16 45 34.125 118.3 3.47
Gcm2+/2; Foxn1nu/nu
Gcm22/2; Foxn1+/+ 3/16 19 34.125 55.7% 228.8 6.70
Gcm22/2; Foxn1nu/+
Gcm22/2; Foxn1nu/nu 1/16 2 11.375 17.6% 87.9 7.73
total 1 182 182 19.71
d = deviation value, or subtraction of the expected from observed for each group.
e = expected number.
chi-square value (X2) = 19.71; P,0.001; degrees of freedom (df) = 3.
doi:10.1371/journal.pgen.1001251.t002
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Materials and Methods
Ethics Statement
All experiments using mice were carried out at UGA with the
approval of the UGA Institutional Animal Care and Use
Committee. First and second trimester human fetuses were
obtained in collaboration with the Reproductive Biology Unit,
Little France, Edinburgh. Ethical approval for use of human fetal
tissue was granted by the Lothian University Hospitals NHS Trust
and the Lothian Research Ethics Committee: Smith et. al.
‘Isolation and propagation of fetal stem cells’ LREC/2002/6/
15. Consent was obtained from all donors, and the tissue was
anonymized before being made available for research. Use and
disposal of tissues are strictly regulated in accordance with
conditions stipulated in the Ethics approval and in the University
of Edinburgh Health and Safety regulations regarding use of
human tissue. All experiments using human tissue were performed
at the University of Edinburgh.
Figure 6. Neither thymectomy nor the Foxn1nu mutation exacerbated the hypoparathyroidism phenotype in Gcm22/2mutants. (A–B)
Ionized calcium and inorganic phosphorus concentrations of Gcm22/2 mutants and Gcm2+/2 controls from mock and thymectomized groups.
Thymectomy surgery did not alter ionized calcium and inorganic phosphorus concentration among mock and thymectomized groups with the same
genotype (t test, P.0.05). Serum samples were collected from 1 month old adult mice. (C–D) Ionized calcium and inorganic phosphorus
concentrations of newborn wild-type (WT), Foxn1nu/nu mutants, Gcm22/2 mutants and Gcm22/2 and Foxn1nu/nu double mutants. The serum samples
were collected from newborn mice on the 129S6 and C57BL/6J F1 hybrid genetic background. (E–F) Ionized calcium and inorganic phosphorus
concentrations of adult wild-type (WT), Foxn1nu/nu mutants, Gcm22/2 mutants and Gcm22/2 and Foxn1nu/nu double mutants. The serum samples
were collected from 1 month-old adult mice on the 129S6 and C57BL/6J F1 hybrid genetic background. In panels C–F, Foxn1 null mutation did not
alter ionized calcium and inorganic phosphorus concentration between groups with the same Gcm2 genotype (t test, P.0.05). In all panels, n = the
number of mice analyzed.
doi:10.1371/journal.pgen.1001251.g006
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Mice
The generation and genotyping of Gcm2 null mutant has been
described [4]. Gcm2 mutant mice on a 129/SvEv-C57BL/6J
genetic background were backcrossed to C57BL/6J mice for more
than 5 generations. These majority C57BL/6J Gcm2 mutant mice
were then backcrossed to 129S6 mice (Taconic) to obtain 129S6/
C57BL/6 F1 hybrids.
Foxn1-nude mice (Jackson Labs) and R26YFP reporter mice [40]
were maintained on a C57BL/6J and 129SvJ hybrid background.
C57BL/6J Rag2 null mutant mice were a generous gift from Dr.
E. V. Rothenberg. The Foxn1Cre allele of Foxn1 was previously
described [41].
Analysis of Gcm2;Foxn1 double mutants was done by mating
Gcm2+/2; Foxn1+/nu males with Gcm2+/2; Foxn1+/nu females. A total
of 182 one month old mice from Gcm2+/2; Foxn1+/nu mating were
genotyped at weaning. Reduced survival of genotypes homozygous
for the Gcm2 mutation was significant using the chi-square test.
Since there were no survival defects detected in Gcm2+/2 or
Foxn1+/nu heterozygous mice, we combined heterozygous mice
with wild-type mice as a control group.
In all crosses, for calculating the % survival, the survival of wild-
type mice was set at 100%. For staging of embryos, noon on the
day of the vaginal plug was designated as E0.5.
Human Fetal Tissue
Embryos were staged according to the standard head/rump
measurement and classified according to Carnegie stages.
Embryos used in this study were from week 6 (Carnegie stage
16–17), week 7 (Carnegie stage 18–19) and early to mid-week 8
(Carnegie stage 20–21). Embryos were fixed in 4% PFA for
24 hours and stored at 220uC in 100% methanol until used for
analysis.
RT-PCR and Semi-Quantitative RT-PCR
Isolation of RNA and RT-PCR were performed as described
[42]. Tissues were dissected from embryos, newborns, or adult
mice and total RNA was isolated with Trizol. Genomic DNA was
removed using DNase I. Reverse transcription was performed
using SuperScript III Reverse Transcriptase (Invitrogen), then
cDNA was subjected to PCR. The following primers were used: b-
actin forward 59-TGGAATCCTGTGGCATCCATGAAAC-39,
b-actin reverse 59-TAAAACGCAGCTCAGTAACAGTCCG-39,
Pth forward 59-CTGCAGTCCAGTTCATCAGC-39, Pth reverse
59-AAGCTTGAAAAGGTAGCAGCA-39, Gcm2 forward 59-CA-
TCAATGACCCACAGATGC-39, Gcm2 reverse 59-GGCAC-
TTCTTCTGCCTTCTG-39, Foxn1 forward 59-TGACGGAG-
CACTTCCCTTAC-39, Foxn1 reverse 59-GGGAAAGGTGT-
GGGTAGGTC-39, Gcm1 forward 59-TGAAAAACAAGCC-
CTTCAGC-39 and Gcm1 reverse 59-TCTGGCTTTGTCACA-
GATGG-39. Both Gcm2 and Pth RT-PCR products were
confirmed by sequencing.
In Situ Hybridization
Paraffin section in situ hybridization for Gcm2 and Pth was
performed as described [3]. Staged embryos were fixed in 4%
paraformaldehyde overnight and processed for paraffin embed-
ding. 8-10 mm sections were hybridized with digoxigenin-labeled
RNA probes at 0.5 mg/ml. Alkaline phosphatase-conjugated
antidigoxigenin Fab fragments were used at 1:5000. BM-purple
(Roche) was used as a chromagen to localize hybridized probe.
Nuclear fast red was used as a counterstain.
Whole-mount in situ hybridization on human fetal tissue was
performed as described [21]. Gcm2 probes used were generated
by PCR amplification from microdissected human fetal thymic/
parathyroid tissue using the following primers: Gcm2F, 59-
GGGCCACCTCCTATGAAAAT-39; Gcm2R, 59-GCAGCC-
TCTAGGGATGTGAA-39. NBT/BCIP (Roche) was used to
localize the hybidized probe. Embryos were embedded in paraffin
and sectioned after staining in whole mount.
Thymic Epithelial Cell Purification
Thymic stromal cell isolation was modified from a previously
described method [43]. Thymi from Foxn1+/Cre;R26-YFP+/tg mice
were dissected, minced into small pieces and agitated in
RPMI1640 with 2% FBS to remove most thymocytes. The
remaining tissue pieces were collected and resuspended in
RPMI1640 and 0.2 mg/ml collagenase for 20 minutes at 37uC
with gentle stirring. The tissue pieces were allowed to settle for 5
minutes, the supernatant was discarded, and the tissue was
resuspended in dispase media (0.2 mg/ml of dispase, 0.2 mg/ml
of collagenase and 25 ug/ml of DNaseI in RPMI 1640) for 20
minutes at 37uC with gentle stirring. The supernatant was
discarded and the tissue chunks resuspended in fresh dispase
media for 30–45 minutes at 37uC. The digested products were
then passed through a 25 G needle, centrifuged at 8006 g for
3minutes, resuspended in PBS containing 2% FBS and 5 mM
EDTA, and then filtered through a 70 um cell strainer. The
filtered cells were stained with anti-mouse CD45-PE (BD
pharmingen) antibody before being subjected to sorting using a
MoFlo cell sorter (Dako) to isolate PE-, YFP+ TECs. The yield of
TECs was about 20,000 cells per adult thymus, with about 93%
purity.
RNA Preparation and Quantitative RT-PCR
Total RNA from sorted TECs was extracted with the RNeasy
Micro kit according to manufacturer’s instructions (QIAGEN).
Total RNA from whole thymi was isolated with Trizol (Invitro-
gen). First-strand cDNA was reverse transcribed using superscript
III (Invitrogen). Quantitative PCR was performed on an ABI 7500
real time PCR system with Taqman universal PCR mix (Applied
Biosystems). 18S rRNA VIC/TAMRA primer-probe (Applied
Biosystems) was used as endogenous control. Pth FAM primer-
probe (Assay ID: Mm00451600-g1) was purchased from Applied
Biosystems. PCR was performed at 50uC, 2 min; 95uC, 10 min;
40 cycles of 95uC for 15 sec; 60uC for 1 min. The relative quantity
of gene expression was determined using 7500 SDS software
(Applied Biosystems).
Serum Biochemistry
Serum sample collection from E18.5 fetal, newborn or adult
mice has been described [44,45]. For fetal or newborn mice, the
neck was incised to transect the carotid and jugular, and whole
blood was collected into plain capillary tubes. For adult mice,
blood samples were collected into capillary tubes from tail vein
right after mice were sacrificed by cervical dislocation, or a
cardiac puncture was used to obtain larger samples. Serum
samples were prepared by centrifugation to remove blood cells,
then stored at 220uC until assayed. The inorganic phosphorus
and ionized calcium levels were measured using kits 117-30 (for
phosphorus) and 140-20 (for calcium) from Diagnostic Chem-
icals Limited (Canada). Serum PTH was measured with a rodent
PTH 1-34 Elisa kit with a detection limit of 1.6 pg/ml
(Immutopics, San Clemente, CA). PTH values that were below
the detection limit of 1.6 were reassigned a value equal to the
detection limit.
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Thymectomy
Neonatal thymecotomy was performed as described [46]. Each
newborn pup was chilled on ice for 1 minute, until unresponsive. A
small incision was made in the center of the throat. The
submandibular gland and muscle were moved aside with forceps,
and the top portion of the sternum cut to expose the thymus. The
thymus was removed with a kimwipe-covered toothpick, and the
sternum and skin closed with surgical adhesive (3 M Vetbond,
No. 1469SB, 3 M Animal Care Products, St. Paul, MN, USA).
Pups were revived on a 37uC warming plate, then returned to their
mother. Mock surgeries were performed without removing the
thymus. All mice were allowed to grow until 1 month of age, then
serum samples were prepared for serum biochemistry as described
above.
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